<?xml version="1.0" encoding="iso-8859-1"?>
<!-- generator="FeedCreator 1.7.2" -->
<rss version="2.0">
    <channel>
        <title>MedWorm Tags: class action</title>
        <description>MedWorm provides a medical RSS filtering service. Over 6000 RSS medical sources are combined and output via different filters. This feed contains the latest medical blog items that have been tagged with 'class action'.</description>
        <link><![CDATA[http://www.medworm.com/rss/search.php?qu=%22class+action%22&t=%22class+action%22&r=Exact&o=d&f=tag]]></link>
        <lastBuildDate>Sat, 03 Sep 2011 02:24:47 +0100</lastBuildDate>
        <item>
            <title>When Will The First Class Action Lawsuits On Health IT-Related Injuries and Deaths Occur?</title>
            <link>http://www.medworm.com/index.php?rid=4762728&amp;cid=t_289170_87_f&amp;fid=34765&amp;url=http%3A%2F%2Fhcrenewal.blogspot.com%2F2011%2F04%2Fwhen-will-first-class-action-lawsuit-on.html</link>
            <description>At this post a few weeks ago about FDA (non)regulation of health IT, I observed several salient points:FDA's Chair of the Center for Device and Radiological Health (CDRH) Dr. Jeffrey Shuren, a physician and lawyer, stated that under the Federal, Food, Drug, and Cosmetic Act [that regulates all drug, medical devices, etc. in the United States - ed.] HIT software is a medical device (link to testimony);FDA is aware of HIT risks of injury and death, including specific examples, and issued an internal memo (direct link to memo PDF) taxonomizing these risks in great detail. The memo was publicly divulged by the Huffington Post Investigative Fund; The aforementioned chair of CDRH believes these incidents - including 44 reported injuries and 6 reported deaths - are likely just the &quot;tip of the ice...</description>
            <author>Health Care Renewal</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4762728</comments>
            <pubDate>Thu, 28 Apr 2011 17:21:00 +0100</pubDate>
            <guid isPermaLink="false">4762728</guid>        </item>
        <item>
            <title>Prop 19, Employment at Will, and Social Peace</title>
            <link>http://www.medworm.com/index.php?rid=4133675&amp;cid=t_289170_87_f&amp;fid=36438&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FCato-at-liberty%2F%7E3%2F5jjDY7jFbOw%2F</link>
            <description>By Walter OlsonWriting at CNN, my colleague Jeffrey Miron puts his finger on one reason for the disappointing defeat of California&amp;#8217;s Prop 19:
Prop 19 failed also because it overreached. One feature attempted to protect the &amp;#8220;rights&amp;#8221; of employees who get fired or disciplined for using marijuana, including a provision that employers could only discipline marijuana use that &amp;#8220;actually impairs job performance.&amp;#8221; That is a much higher bar than required by current policy.
Like so many other developments in employment law in recent years, this would have chipped away at the basic principle of employment at will, which holds that in the absence of a contract specifying otherwise, either party to an employment relation may end that relation at any time for any reason or f...</description>
            <author>Cato-at-liberty</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4133675</comments>
            <pubDate>Thu, 04 Nov 2010 01:39:47 +0100</pubDate>
            <guid isPermaLink="false">4133675</guid>        </item>
        <item>
            <title>The Libertarian Case against the Google Book Search Deal</title>
            <link>http://www.medworm.com/index.php?rid=2793136&amp;cid=t_289170_87_f&amp;fid=36438&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FCato-at-liberty%2F%7E3%2FwDbkAurfUmk%2F</link>
            <description>Five years ago, Google began scanning millions of books for inclusion in what eventually became Google Book Search. Google carefully designed the service to stay within the boundaries of copyright&amp;#8217;s fair use provisions, at least as Google interpreted them. Still, some authors and publishers objected, and in 2005 they filed a lawsuit accusing Google of copyright infringement. The lawsuit dragged on for more than three years. Finally, in 2008, the parties announced a settlement of the lawsuit. Its text runs for 140 pages, not counting a secret termination clause available only to Google and its adversaries. The deadline for comments on the settlement was earlier this month, and on October 7 a federal judge must decide whether to approve or reject the settlement.
I was (and still am) fi...</description>
            <author>Cato-at-liberty</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2793136</comments>
            <pubDate>Mon, 14 Sep 2009 14:07:12 +0100</pubDate>
            <guid isPermaLink="false">2793136</guid>        </item>
        <item>
            <title>Locking up Kids with Mental Illness</title>
            <link>http://www.medworm.com/index.php?rid=2699657&amp;cid=t_289170_109_f&amp;fid=34750&amp;url=http%3A%2F%2Fpsychcentral.com%2Fblog%2Farchives%2F2009%2F08%2F13%2Flocking-up-kids-with-mental-illness%2F</link>
            <description>A few weeks ago, we wrote about the opening of a mental health court in Philadelphia to help deal with a problem that&amp;#8217;s overwhelming the U.S. justice system &amp;#8212; poor mental health care in prisons, affecting up to 30 percent of those incarcerated.
Some of the problems our prisons face can be traced back to a pretty straightforward issue &amp;#8212; our prisons are overcrowded. For instance, the prisons have been so overcrowded in California, the California prison system has been under a federal court&amp;#8217;s oversight for years. And that court has become so frustrated by California&amp;#8217;s lack of interest in the humane treatment of their prisoners, they recently ordered the number of prisoners cut by 27 percent within two years. The case that resulted in the court order began as the ...</description>
            <author>World of Psychology</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2699657</comments>
            <pubDate>Thu, 13 Aug 2009 13:05:14 +0100</pubDate>
            <guid isPermaLink="false">2699657</guid>        </item>
        <item>
            <title>Court Reinstates Vioxx Lawsuit Against Merck</title>
            <link>http://www.medworm.com/index.php?rid=1782894&amp;cid=t_289170_150_f&amp;fid=35777&amp;url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FPharmalot%2F%7E3%2F387789589%2F</link>
            <description>Last year, Merck thought it had this class-action lawsuit in the bag. But a three-judge panel of the Third Circuit Court of Appeals has reinstated the securities case, which was brought by investors who claimed the drugmaker failed to disclose info concerning the Vioxx painkiller (here is the decision). A federal district court judge dimissed the lawsuit after ruling the clock had run out on the statute of limitations. 
In a statement, Merck says it may pursue an appeal with the full court of appeals or the US Supreme Court. &amp;#8220;Merck presented several alternative grounds for dismissing the lawsuit. In reaching his April 2007 decision to dismiss the suit, the district judge considered arguments regarding the timeliness of the suit, but did not address the alternative grounds for dismiss...</description>
            <author>Pharmalot</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1782894</comments>
            <pubDate>Tue, 09 Sep 2008 16:13:55 +0100</pubDate>
            <guid isPermaLink="false">1782894</guid>        </item>
        <item>
            <title>Lilly Faces Zyprexa Class Action By 3rd-Party Payors</title>
            <link>http://www.medworm.com/index.php?rid=1770725&amp;cid=t_289170_150_f&amp;fid=35777&amp;url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FPharmalot%2F%7E3%2F384696202%2F</link>
            <description>Insurers, labor unions and pension funds can proceed with a class-action suit that claims they were overcharged by the drugmaker, which allegedly withheld information and disseminated misinformation about the safety and effectiveness of the antipsychotic, according to a hefty, 295-page opinion by US District Court Judge Jack Weinstein (pictured at left). His decision comes two months after he urged Lilly to settle.
Interestingly, Weinstein writes that there is &amp;#8220;sufficient evidence of fraud under RICO, the Racketeer Influenced and Corrupt Organizations Act through mail fraud, predicated on overpricing supported by excessive claims of utility as well as disavowal of secondary effects of the drug, primarily weight gain and diabetes.&amp;#8221; 
At the same time, the federal judge, who is ba...</description>
            <author>Pharmalot</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1770725</comments>
            <pubDate>Sat, 06 Sep 2008 02:41:27 +0100</pubDate>
            <guid isPermaLink="false">1770725</guid>        </item>
        <item>
            <title>Class Action Against Pfizer OKed in Canada</title>
            <link>http://www.medworm.com/index.php?rid=1480735&amp;cid=t_289170_97_f&amp;fid=35050&amp;url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FPharmaGazette%2F%7E3%2F301524013%2Fclass_action_against_pfizer_oked_in_canada.html</link>
            <description>A class-action suit against pharmaceutical Pfizer Inc. and Pfizer Canada Inc. has been approved by a Quebec Superior Court Justice. The suit is to be brought by women who have taken the contraceptive Depo-Provera.Depo-Provera, which received a U.S. Food and Drug Administration black box warning, is an injectable that protects against pregnancy for a period of three months and has also been used in treatment of breast and endometrial cancer and endometriosis.Pfizer issued a public notification in 2005 stating that two clinical trial results showed that the drug may cause users to experience a reduction in bone mineral density especially in menopausal women.Any Canadian women who took the drug and believes they have suffered bone density loss are eligible to join in the class action suit aga...</description>
            <author>PharmaGazette</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1480735</comments>
            <pubDate>Fri, 30 May 2008 19:00:51 +0100</pubDate>
            <guid isPermaLink="false">1480735</guid>        </item>
        <item>
            <title>Merck Set To Pay $4.85 Billion To Settle On Vioxx Lawsuits</title>
            <link>http://www.medworm.com/index.php?rid=1019422&amp;cid=t_289170_111_f&amp;fid=36048&amp;url=http%3A%2F%2Ffeeds.b5media.com%2F%7Er%2Fb5media%2FAHeartyLife%2F%7E3%2F183235663%2F</link>
            <description>The maker of Vioxx has agreed to pay $4.85bn to settle legal claims that the controversial drug caused many users to suffer strokes and heart failure.
Holy Potatoes is what I have to say. But I guess it could have been far worse when you really stop and think about it. In order to qualify for compensation you must prove that you suffered serious illness at the most 2 weeks after you purchased the drug.
The above amount of money will be able to settle over 90% of Vioxx lawsuits with the exception of class action suits. Like I said, it could have been worse for Merck.
via Science Daily
Share This (Source: A Hearty Life)</description>
            <author>A Hearty Life</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1019422</comments>
            <pubDate>Sun, 11 Nov 2007 20:36:39 +0100</pubDate>
            <guid isPermaLink="false">1019422</guid>        </item>
        <item>
            <title>C-Peptide - Missing in Action</title>
            <link>http://www.medworm.com/index.php?rid=503970&amp;cid=t_289170_87_f&amp;fid=34867&amp;url=http%3A%2F%2Fwww.thediabetesblog.com%2F2007%2F03%2F27%2Fc-peptide-missing-in-action%2F</link>
            <description>Filed under: Type 1, Type 2, Childhood, Adult Onset, Lifestyle, Drugs, ResearchWhen treating diabetes, today's doctors focus on establishing blood glucose control, but often overlook the need to protect against common diabetic complications such as blindness, kidney damage, and nerve damage. The DCCT, even with a comprehensive treatment program, had a complication rate of approximately 40% of participants.
People who do not have diabetes make insulin with C-peptide. Those of us diabetics who inject synthetic insulin do not get the C-peptide. When scientists began developing insulin - they weeded out the pieces of the amino acid chain they felt were insignificant in lowering blood glucose. Synthetic insulin was designed to reduce the dangerous buildup of excess sugar in the bloodstream. Uh ...</description>
            <author>The Diabetes Blog</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=503970</comments>
            <pubDate>Tue, 27 Mar 2007 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">503970</guid>        </item>
    </channel>
</rss>

